← Back to Search

Behavioral Intervention

Mindfulness Training for PTSD

N/A
Recruiting
Led By Kyle Possemato, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients with gross cognitive impairment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 weeks: baseline, 8 weeks, 16 weeks, 24 weeks
Awards & highlights

Summary

This trial is looking at how mindfulness and problem-solving skills can help Veterans manage anxiety, depression and PTSD. The goal is to reduce symptoms and improve overall functioning.

Who is the study for?
This trial is for Veterans experiencing anxiety, depression, or PTSD and enrolled in VA primary care. They must have significant distress shown by specific scores on mental health assessments. Those with recent suicide attempts, changes in psychiatric meds, or who prefer specialty mental health care are excluded.
What is being tested?
The study compares two treatments: mindfulness meditation (PCBMT) and a problem-solving class (MF). It aims to see if these classes can reduce symptoms of anxiety, depression, PTSD and improve overall functioning among Veterans.
What are the potential side effects?
While the trial doesn't specify side effects, mindfulness training may sometimes cause discomfort like increased anxiety or emotional pain initially. Problem-solving classes are generally low-risk but could potentially lead to frustration or stress.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have significant memory or thinking problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 weeks: baseline, 8 weeks, 16 weeks, 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 weeks: baseline, 8 weeks, 16 weeks, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Depression Anxiety and Stress Scale (DASS-21) Change
Secondary outcome measures
PTSD Checklist for DSM-5 (PCL-5)
Satisfaction with Life Scale (SWLS)
Other outcome measures
Acceptance and Action Questionnaire (AAQ-II)
Demographics and Military Background Questionnaire
Emotion Regulation Questionnaire (ERQ)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Primary Care Brief Mindfulness Training (PCBMT)Experimental Treatment1 Intervention
PCBMT is a manualized intervention that is a brief adaptation of MBSR Mindfulness Based Stress Reduction (MBSR). Instruction encompasses sitting meditation, body scan, moving meditation, gentle yoga, and group discussion on topics such as non-judging, patience, trust, non-striving, acceptance, and letting go.
Group II: Moving Forward (MF)Active Control1 Intervention
Moving Forward (MF) is a transdiagnostic class that seeks to build resilience and reduce emotional distress by teaching step-by-step problem-solving skills such as "stop, slow down, think and act".

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,647 Previous Clinical Trials
3,359,770 Total Patients Enrolled
78 Trials studying Depression
19,644 Patients Enrolled for Depression
Kyle Possemato, PhDPrincipal InvestigatorSyracuse VA Medical Center, Syracuse, NY
2 Previous Clinical Trials
122 Total Patients Enrolled
~200 spots leftby Jul 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top